West Pharmaceutical Services Return on Tangible Equity 2010-2024 | WST
Current and historical return on tangible equity values for West Pharmaceutical Services (WST) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| West Pharmaceutical Services Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2024-09-30 |
$0.50B |
$2.63B |
19.18% |
| 2024-06-30 |
$0.52B |
$2.46B |
19.93% |
| 2024-03-31 |
$0.57B |
$2.56B |
21.27% |
| 2023-12-31 |
$0.59B |
$2.76B |
22.01% |
| 2023-09-30 |
$0.56B |
$2.75B |
21.14% |
| 2023-06-30 |
$0.52B |
$2.62B |
20.39% |
| 2023-03-31 |
$0.55B |
$2.65B |
22.44% |
| 2022-12-31 |
$0.59B |
$2.56B |
24.97% |
| 2022-09-30 |
$0.63B |
$2.35B |
27.95% |
| 2022-06-30 |
$0.69B |
$2.30B |
31.36% |
| 2022-03-31 |
$0.69B |
$2.20B |
32.77% |
| 2021-12-31 |
$0.66B |
$2.20B |
33.71% |
| 2021-09-30 |
$0.61B |
$2.07B |
33.23% |
| 2021-06-30 |
$0.52B |
$1.90B |
30.13% |
| 2021-03-31 |
$0.42B |
$1.69B |
26.17% |
| 2020-12-31 |
$0.35B |
$1.71B |
22.57% |
| 2020-09-30 |
$0.31B |
$1.58B |
21.31% |
| 2020-06-30 |
$0.29B |
$1.47B |
20.32% |
| 2020-03-31 |
$0.26B |
$1.36B |
19.08% |
| 2019-12-31 |
$0.24B |
$1.44B |
18.05% |
| 2019-09-30 |
$0.23B |
$1.35B |
17.70% |
| 2019-06-30 |
$0.23B |
$1.31B |
18.07% |
| 2019-03-31 |
$0.22B |
$1.25B |
17.82% |
| 2018-12-31 |
$0.21B |
$1.27B |
17.17% |
| 2018-09-30 |
$0.16B |
$1.23B |
13.18% |
| 2018-06-30 |
$0.15B |
$1.15B |
12.94% |
| 2018-03-31 |
$0.13B |
$1.17B |
11.59% |
| 2017-12-31 |
$0.15B |
$1.15B |
13.44% |
| 2017-09-30 |
$0.19B |
$1.19B |
17.54% |
| 2017-06-30 |
$0.18B |
$1.11B |
17.02% |
| 2017-03-31 |
$0.18B |
$1.04B |
18.18% |
| 2016-12-31 |
$0.14B |
$0.99B |
14.67% |
| 2016-09-30 |
$0.14B |
$1.01B |
14.46% |
| 2016-06-30 |
$0.10B |
$0.98B |
11.16% |
| 2016-03-31 |
$0.09B |
$0.94B |
9.66% |
| 2015-12-31 |
$0.10B |
$0.88B |
11.38% |
| 2015-09-30 |
$0.09B |
$0.85B |
11.40% |
| 2015-06-30 |
$0.12B |
$0.85B |
15.07% |
| 2015-03-31 |
$0.13B |
$0.80B |
16.46% |
| 2014-12-31 |
$0.13B |
$0.81B |
15.84% |
| 2014-09-30 |
$0.12B |
$0.82B |
15.26% |
| 2014-06-30 |
$0.12B |
$0.81B |
15.44% |
| 2014-03-31 |
$0.11B |
$0.77B |
15.35% |
| 2013-12-31 |
$0.11B |
$0.74B |
17.21% |
| 2013-09-30 |
$0.11B |
$0.68B |
17.97% |
| 2013-06-30 |
$0.10B |
$0.62B |
16.83% |
| 2013-03-31 |
$0.08B |
$0.59B |
15.09% |
| 2012-12-31 |
$0.08B |
$0.57B |
14.92% |
| 2012-09-30 |
$0.08B |
$0.56B |
15.07% |
| 2012-06-30 |
$0.08B |
$0.52B |
15.67% |
| 2012-03-31 |
$0.09B |
$0.53B |
16.40% |
| 2011-12-31 |
$0.08B |
$0.49B |
14.94% |
| 2011-09-30 |
$0.06B |
$0.53B |
12.59% |
| 2011-06-30 |
$0.06B |
$0.53B |
13.20% |
| 2011-03-31 |
$0.07B |
$0.49B |
14.47% |
| 2010-12-31 |
$0.07B |
$0.46B |
15.14% |
| 2010-09-30 |
$0.08B |
$0.46B |
18.88% |
| 2010-06-30 |
$0.08B |
$0.41B |
19.42% |
| 2010-03-31 |
$0.08B |
$0.41B |
19.31% |
| 2009-12-31 |
$0.07B |
$0.41B |
18.96% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$23.854B |
$2.950B |
|
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
|
